Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Official Title Neoadjuvant Immunotherapy in Sarcomatoid Mesothelioma

NCT05647265 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT05647265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05647265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Official Title Neoadjuvant Immunotherapy in Sarcomatoid Mesothelioma
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 2
Overall status
Recruiting
Start date
November 27, 2024
Completion date
December 15, 2026
Enrollment
26 (estimated)
Sites
132

Conditions

As the registry lists them; a condition with its own page is linked.

pleural biphasic mesothelioma, pleural sarcomatoid mesothelioma